Immunohistochemistry Market by Product & Service, Application

List of Tables

The immunohistochemistry market is expected to reach USD 5.14 billion in 2030 from USD 3.55 billion in 2024, at a CAGR of 7.6% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Offering, Application, End User
Regions covered	North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

Factors propelling the growth of the market are the increased prevalence of cancer cases among the growing geriatric population and the rising application of IHC tests for the diagnosis and management of cancer. Moreover, the development of companion diagnostics (CDx) and its integration with IHC technology to develop personalized medicine further support the expansion of the market.

The histological stain segment accounted for the largest share of the immunohistochemistry reagents segment in 2024.

The market is segmented into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, diluents, organic solvents, proteolytic enzymes, and other reagents. In 2024, the histological stains segment accounted for the largest share of the immunohistochemistry market. This is due to their primary application being in immunohistochemistry, a powerful technique where stains are used to visualize and differentiate specific cellular components, proteins, and structures within tissue samples by leveraging antigen-antibody interactions. This allows for the precise localization of biomarkers critical for diagnosis and research. Furthermore, the utility of histological stains is expanding through advanced techniques like multiplex staining, also known as multiple staining. This method employs several stains simultaneously to detect multiple targets within a single tissue section. This is particularly valuable in fields like immuno-oncology as it conserves precious patient samples while providing a comprehensive view of the complex tumor microenvironment. A major driver for this market remains its pivotal function in cancer diagnosis, where pathologists use these stains to distinguish between normal and abnormal tissue morphology, thereby determining tumor grade and type.

In 2024, by application, the research applications segment accounted for the second-largest share of the market.

The immunohistochemistry market is segmented into diagnostic applications, research applications, and forensic applications. In 2024, the research applications segment accounted for the second-largest share of the immunohistochemistry market. IHC technology is a cornerstone of modern biomedical investigation, particularly in anti-tumor drug development and biomarker discovery. It provides researchers with an unparalleled ability to visualize the expression and precise subcellular location of specific proteins within the contextual architecture of tissue. This is fundamental to understanding the complex cellular mechanisms that underpin cancer and other diseases. For instance, in the exploration of the cancer proteome, IHC is instrumental for validating new drug targets identified through genomic or proteomic screening, confirming their presence and relevance in actual tumor tissues. The role of IHC in research extends across numerous scientific disciplines. In developmental biology and embryological studies, it allows for mapping key regulatory proteins during different stages of development, offering insights crucial for understanding morphogenesis and congenital disorders. Similarly, in stem cell research, IHC is used to monitor markers of proliferation and differentiation, providing essential data on stem cell behavior and therapeutic potential. The continuous investment in R&D by pharmaceutical and biotechnology companies, coupled with the global push towards personalized medicine, ensures that the research application segment will remain a dynamic and expanding component of the immunohistochemistry market.

In 2024, North America accounted for the largest share of the immunohistochemistry market.

North America accounted for the largest share of the immunohistochemistry market in 2024. This leadership position is underpinned by various factors, including the region's highly advanced healthcare infrastructure, substantial healthcare expenditure, and the robust presence of key market players and leading research institutions. The US, in particular, serves as the primary driver of this growth, fueled by a high prevalence of chronic diseases, most notably cancer. The significant and rising incidence of various cancers necessitates sophisticated and accurate diagnostic tools, with IHC being a cornerstone of modern pathology for tumor classification and biomarker analysis. Furthermore, the region benefits from extensive government and private funding for biomedical research and development, which accelerates the adoption of innovative IHC technologies and automated platforms. Favorable reimbursement policies and a high level of awareness among clinicians and patients regarding advanced diagnostic options also contribute to the market's expansion. The strong regulatory framework, while stringent, ensures the quality and reliability of IHC products, fostering trust and widespread use in both clinical diagnostics and the burgeoning pharmaceutical and biotechnology research sectors, solidifying the preeminent standing of North America in the global IHC landscape.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Tier 1-25%, Tier 2-35%, and Tier 3- 40%
By Designation: C-level Executives - 55%, Directors- 20%, and Others- 25%
By Region: North America -45%, Europe - 20%, Asia Pacific -20%, Latin America -10%, the Middle East- 3%, and Africa-2%

F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Bio-Techne (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), PHC Holdings Corporation (Japan), Enzo Biochem Inc. (US), Sino Biological, Inc. (China), OriGene Technologies, Inc. (US), Cell Signaling Technology, Inc. (US), Bio SB (US), Miltenyi Biotec (Germany), Sakura Finetek (US), EagleBio (US), Biocare Medical LLC (US), Elabscience BioInnovation Inc. (US), Bio-Genex (US), Diagnostic BioSystems Inc. (US), Histo-Line Laboratories (Italy), Rockland Immunochemicals, Inc. (US), and CANDOR Bioscience GmbH (Germany) are some of the key companies offering immunohistochemistry products.

Research Coverage

This research report categorizes the immunohistochemistry market by Product & Service, Product (Antibodies [Primary antibodies, secondary antibodies], [Clonality {Monoclonal, Polyclonal}], [Regulatory Class {Class I/II Assay Antibodies, Class III Assay Antibodies}], Reagents [blocking sera and reagents, chromogenic substrates, fixation reagents, diluents, organic solvents, proteolytic enzymes, other reagents], Kits [Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits], Instruments & Software (IHC Stainers), [Sample Preparation Instruments {Tissue Processors, Microtomes, Other Sample Preparation Instruments}], (Image Analysis Instruments), Service, Application (Diagnostic Applications [Cancer, Infectious Diseases, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Other Diseases] Research Applications [Drug Development and testing, Other Research Applications], Forensic Applications}, End User for Product (Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Contract Research Organizations, Other End Users), End User for Service (Pharmaceutical & Biotechnology Companies and Academic Institutions) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the immunohistochemistry market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, acquisitions, and recent developments associated with the immunohistochemistry market. This report covers a competitive analysis of top players and upcoming startups in the immunohistochemistry market ecosystem.

The scope of the report covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the immunohistochemistry market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the immunohistochemistry market. This report covers the competitive analysis of upcoming startups in the immunohistochemistry market ecosystem.

Key Benefits of Buying the Report

This report provides a detailed picture of the immunohistochemistry market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

The report provides insights on the following pointers:

Analysis of key drivers (Rising Geriatric Population and Increasing Cancer Prevalence, Innovations and advancements in Immunohistochemistry (IHC) Technology, Reimbursement Coverage for Immunohistochemistry (IHC) Tests, Rising Adoption of Digital Pathology), restraint (Adoption of alternative technologies and a high degree of consolidation), opportunities (Rising demand for personalized medicine, Growing adoption of companion diagnostics, Growth opportunities in emerging countries, Integration of artificial intelligence in IHC), Challenges (Stringent regulatory requirements, Lack of Standardization)

Product Development/Innovation: Detailed insights on newly launched product, and technological assessment of the Immunohistochemistry market.
Market Development: Comprehensive information about lucrative markets - the report analyses the Immunohistochemistry market across varied regions.
Market Diversification: Exhaustive information about new, untapped geographies, recent developments, and investments in the Immunohistochemistry market

Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like F. Hoffman-La Roche Ltd (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US) among others in the Immunohistochemistry market. The report also helps stakeholders understand the pulse of the IHC market and provides them with information on key market drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the GLP-1 analogues market.

Product Code: BT 4780

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key sources of secondary data
  - 2.1.1.2 Key objectives of secondary research
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Breakdown of primaries
  - 2.1.2.2 Key objectives of primary research
2.2 MARKET SIZE ESTIMATION
- 2.2.1 GLOBAL MARKET SIZE ESTIMATION
  - 2.2.1.1 Revenue share analysis (bottom-up approach)
  - 2.2.1.2 Secondary data
  - 2.2.1.3 Primary interviews and MnM repository analysis
- 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
- 2.2.3 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS
3.3 DISRUPTIVE TRENDS SHAPING IMMUNOHISTOCHEMISTRY MARKET
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
3.5 GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

4 PREMIUM INSIGHTS

4.1 IMMUNOHISTOCHEMISTRY MARKET OVERVIEW
4.2 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION AND COUNTRY, 2024
4.3 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET SHARE, BY END USER, 2024
4.4 IMMUNOHISTOCHEMISTRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 UNMET NEEDS & WHITE SPACES
4.6 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.7 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
4.8 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.9 VC/PRIVATE EQUITY INVESTMENT TRENDS
4.10 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing adoption of companion diagnostics
  - 5.2.1.2 Favorable reimbursement coverage for immunohistochemistry tests
  - 5.2.1.3 Growing focus on digital pathology
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Adoption of alternative technologies in molecular diagnostics and research
  - 5.2.2.2 Highly consolidated global market
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Rising demand for precision/personalized medicines
  - 5.2.3.2 High growth opportunities in emerging economies
  - 5.2.3.3 Integration of AI in immunohistochemistry
- 5.2.4 CHALLENGES
  - 5.2.4.1 Stringent regulatory requirements for tissue diagnostic instruments and consumables
  - 5.2.4.2 Lack of preanalytical and analytical method standardization
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF IMMUNOHISTOCHEMISTRY PRODUCTS, BY KEY PLAYER, 2022-2024
- 5.4.2 AVERAGE SELLING PRICE TREND OF IMMUNOHISTOCHEMISTRY PRODUCTS, BY REGION, 2022-2024
5.5 TECHNOLOGY ANALYSIS
- 5.5.1 KEY TECHNOLOGIES
  - 5.5.1.1 Automated immunohistochemistry systems
  - 5.5.1.2 Multiplex immunohistochemistry
- 5.5.2 COMPLEMENTARY TECHNOLOGIES
  - 5.5.2.1 Chromogenic detection
  - 5.5.2.2 Fluorescent detection
- 5.5.3 ADJACENT TECHNOLOGIES
  - 5.5.3.1 In situ hybridization
5.6 PATENT ANALYSIS
- 5.6.1 METHODOLOGY
- 5.6.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
- 5.6.3 LIST OF KEY PATENTS
5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA FOR HS CODE 3822.00, 2020-2024
- 5.7.2 EXPORT DATA FOR HS CODE 3822.00, 2020-2024
5.8 VALUE CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
- 5.9.1 ROLE IN ECOSYSTEM
5.10 PORTER'S FIVE FORCES ANALYSIS
- 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.10.2 BARGAINING POWER OF SUPPLIERS
- 5.10.3 BARGAINING POWER OF BUYERS
- 5.10.4 THREAT OF SUBSTITUTES
- 5.10.5 THREAT OF NEW ENTRANTS
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 KEY BUYING CRITERIA
5.12 TARIFF & REGULATORY ANALYSIS
- 5.12.1 TARIFF DATA ANALYSIS
- 5.12.2 REGULATORY LANDSCAPE
  - 5.12.2.1 North America
    - 5.12.2.1.1 US
    - 5.12.2.1.2 Canada
  - 5.12.2.2 Europe
  - 5.12.2.3 Asia Pacific
    - 5.12.2.3.1 Japan
    - 5.12.2.3.2 China
    - 5.12.2.3.3 India
  - 5.12.2.4 Latin America
    - 5.12.2.4.1 Brazil
- 5.12.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 KEY CONFERENCES & EVENTS, 2025-2026
5.14 INVESTMENT & FUNDING SCENARIO
5.15 IMPACT OF AI/GEN AI ON IMMUNOHISTOCHEMISTRY MARKET
5.16 IMPACT OF 2025 US TARIFF ON IMMUNOHISTOCHEMISTRY MARKET
- 5.16.1 KEY TARIFF RATES
- 5.16.2 PRICE IMPACT ANALYSIS
- 5.16.3 IMPACT ON KEY COUNTRIES/REGIONS
  - 5.16.3.1 North America
    - 5.16.3.1.1 US
  - 5.16.3.2 Europe
  - 5.16.3.3 Asia Pacific
  - 5.16.3.4 Rest of the World
- 5.16.4 IMPACT ON END-USE INDUSTRIES
  - 5.16.4.1 Pharmaceutical & biopharmaceutical companies
  - 5.16.4.2 Hospitals & clinics
  - 5.16.4.3 Academic & research institutes
  - 5.16.4.4 Contract research organizations

6 IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING

6.1 INTRODUCTION
6.2 ANTIBODIES
- 6.2.1 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE
  - 6.2.1.1 Primary antibodies
    - 6.2.1.1.1 Increasing adoption of targeted immunotherapy and custom antibody development to drive segment
  - 6.2.1.2 Secondary antibodies
    - 6.2.1.2.1 Better signal amplification and easier manufacturing process to fuel segment growth
- 6.2.2 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY
  - 6.2.2.1 Monoclonal antibodies
    - 6.2.2.1.1 Increased applications in cancer diagnostics to support segment growth
  - 6.2.2.2 Polyclonal antibodies
    - 6.2.2.2.1 Better sensitivity and higher resistance to changes in antigen conformation to augment segment growth
- 6.2.3 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS
  - 6.2.3.1 Class I/II assay antibodies
    - 6.2.3.1.1 Focus on precision medicine and standardized reagents to favor segment growth
  - 6.2.3.2 Class III assay antibodies
    - 6.2.3.2.1 Expansion of targeted therapies to augment segment growth
6.3 REAGENTS
- 6.3.1 BLOCKING SERA & REAGENTS
  - 6.3.1.1 Need to prevent non-specific binding and provide accurate outcomes to drive adoption
- 6.3.2 CHROMOGENIC SUBSTRATES
  - 6.3.2.1 Rapid detection and faster diagnosis to propel segment growth
- 6.3.3 FIXATION REAGENTS
  - 6.3.3.1 Increased focus on retaining tissue morphology and antigenicity of target molecules to support adoption
- 6.3.4 ORGANIC SOLVENTS
  - 6.3.4.1 Need to prevent physical damage in specimens and improve clarity in tissue sample visualization to drive market
- 6.3.5 PROTEOLYTIC ENZYMES
  - 6.3.5.1 Proteolytic enzymes to improve accessibility of target antibodies and DNA
- 6.3.6 DILUENTS
  - 6.3.6.1 Need for reducing non-specific background staining during immunostaining to aid segment growth
- 6.3.7 OTHER REAGENTS
6.4 KITS
- 6.4.1 HUMAN IMMUNOHISTOCHEMISTRY KITS
  - 6.4.1.1 Increasing focus on cancer research to fuel segment growth
- 6.4.2 ANIMAL IMMUNOHISTOCHEMISTRY KITS
  - 6.4.2.1 Rising focus on drug safety and efficacy in preclinical drug testing to boost segment growth
6.5 INSTRUMENTS & SOFTWARE
- 6.5.1 IHC STAINERS
  - 6.5.1.1 Increased availability of automated IHC stainers to fuel segment growth
- 6.5.2 SAMPLE PREPARATION INSTRUMENTS
  - 6.5.2.1 Tissue processors
    - 6.5.2.1.1 Rising biopsy volumes and increasing workflow automation to fuel segment growth
  - 6.5.2.2 Microtomes
    - 6.5.2.2.1 High precision demand and increased workforce challenges to aid segment growth
  - 6.5.2.3 Other sample preparation instruments
- 6.5.3 IMAGE ANALYSIS INSTRUMENTS
  - 6.5.3.1 Escalating demand for objective and reproducible quantification of IHC-stained tissue to boost segment growth
6.6 SERVICES
- 6.6.1 INCREASED COMPLEXITY OF BIOMARKER REQUIREMENTS AND EXPANSION OF GLOBAL CLINICAL TRIALS TO AID MARKET GROWTH

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 DIAGNOSTIC APPLICATIONS
- 7.2.1 CANCER
  - 7.2.1.1 Automation, AI-enhanced quantitation, and multiplexing to accelerate global cancer IHC adoption
- 7.2.2 INFECTIOUS DISEASES
  - 7.2.2.1 Multiplex pathogen panels, automation, and AI-driven imaging to boost market growth
- 7.2.3 AUTOIMMUNE DISEASES
  - 7.2.3.1 Focus on AI-powered multiplex imaging and automated analysis to propel market growth
- 7.2.4 NEPHROLOGICAL DISEASES
  - 7.2.4.1 Better understanding of novel renal biomarkers and virtual multiplexing to accelerate market growth
- 7.2.5 NEUROLOGICAL DISEASES
  - 7.2.5.1 Advances in neuroimmunopathology, novel biomarker discovery, multiplexing, and AI-supported image analysis to drive market
- 7.2.6 OTHER DIAGNOSTIC APPLICATIONS
7.3 RESEARCH APPLICATIONS
- 7.3.1 DRUG DEVELOPMENT & TESTING
  - 7.3.1.1 AI-enabled quantitation, regulatory support, and organ-on-chip integration to propel growth in drug development
- 7.3.2 OTHER RESEARCH APPLICATIONS
7.4 FORENSIC APPLICATIONS
- 7.4.1 ADVANCEMENTS IN VALIDATED INJURY AND DEATH MARKERS WITH IHC INTEGRATION IN FORENSIC IMAGING TO DRIVE MARKET

8 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER

8.1 INTRODUCTION
8.2 HOSPITALS & DIAGNOSTIC LABORATORIES
- 8.2.1 EXPANSION OF DIAGNOSTIC INFRASTRUCTURE AND DIGITAL AUTOMATION TO DRIVE GLOBAL MARKET GROWTH
8.3 ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS
- 8.3.1 INNOVATION IN MULTIPLEX AND AI-ENABLED IMMUNOHISTOCHEMISTRY TO FUEL GLOBAL MARKET EXPANSION
8.4 OTHER END USERS

9 IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER

9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 9.2.1 INTEGRATION OF MULTIPLEX IHC SERVICES WITH REGULATORY-CLEARED WORKFLOWS TO AUGMENT MARKET GROWTH
9.3 ACADEMIC INSTITUTIONS
- 9.3.1 ADOPTION OF MULTIPLEX SPATIAL IMMUNOHISTOCHEMISTRY AND DIGITAL PATHOLOGY TO BOOST MARKET GROWTH

10 IMMUNOHISTOCHEMISTRY MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 US to dominate North American immunohistochemistry market during forecast period
- 10.2.3 CANADA
  - 10.2.3.1 High incidence of cancer and increased demand for advanced diagnostics to propel market growth
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 High investments in life science R&D and favorable reimbursement policies to drive market
- 10.3.3 UK
  - 10.3.3.1 Rising prevalence of cancer and increasing government funding in healthcare research to augment market growth
- 10.3.4 FRANCE
  - 10.3.4.1 Increased research in cancer diagnosis and treatment to support market growth
- 10.3.5 ITALY
  - 10.3.5.1 Advanced healthcare infrastructure and high geriatric population to fuel market growth
- 10.3.6 SPAIN
  - 10.3.6.1 Increased demand for personalized medicines to boost adoption of immunohistochemistry products
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Rising healthcare investments and increasing cancer burden to spur market growth
- 10.4.3 JAPAN
  - 10.4.3.1 High geriatric population and increased government healthcare expenditure to support market growth
- 10.4.4 INDIA
  - 10.4.4.1 Need for high-end pathology and diagnostic services to propel market growth
- 10.4.5 AUSTRALIA
  - 10.4.5.1 Increased patient population and high demand for quality healthcare to aid market growth
- 10.4.6 SOUTH KOREA
  - 10.4.6.1 Focus on precision healthcare and personalized medicines to drive market
- 10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Increasing incidence of chronic lifestyle diseases and rising investments by private companies to fuel market growth
- 10.5.3 MEXICO
  - 10.5.3.1 Increasing research initiatives and rising cancer cases to drive market
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 10.6.2 GCC COUNTRIES
  - 10.6.2.1 Kingdom of Saudi Arabia
    - 10.6.2.1.1 Growing cancer burden and increasing focus on oncology-based research programs to augment market growth
  - 10.6.2.2 UAE
    - 10.6.2.2.1 Favorable government initiatives and high investments in healthcare infrastructure to fuel market growth
  - 10.6.2.3 Rest of GCC Countries
- 10.6.3 REST OF MIDDLE EAST
10.7 AFRICA
- 10.7.1 RAPID RISE IN CANCER CASES AND HIGH HEALTHCARE INVESTMENTS TO DRIVE MARKET
- 10.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMMUNOHISTOCHEMISTRY MARKET
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Offering footprint
  - 11.5.5.4 Application footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 11.6.5.1 Detailed list of key startups/SMEs
  - 11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT APPROVALS
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS
- 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 F. HOFFMANN-LA ROCHE LTD.
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products/Services offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Product launches and approvals
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Key strengths
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 DANAHER CORPORATION
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products/Services offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product launches and approvals
    - 12.1.2.3.2 Deals
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Key strengths
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 AGILENT TECHNOLOGIES, INC.
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products/Services offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Product approvals
    - 12.1.3.3.2 Deals
    - 12.1.3.3.3 Expansions
  - 12.1.3.4 MnM view
    - 12.1.3.4.1 Key strengths
    - 12.1.3.4.2 Strategic choices
    - 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 PHC HOLDINGS CORPORATION
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products/Services offered
  - 12.1.4.3 Recent developments
    - 12.1.4.3.1 Deals
  - 12.1.4.4 MnM view
    - 12.1.4.4.1 Key strengths
    - 12.1.4.4.2 Strategic choices
    - 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 THERMO FISHER SCIENTIFIC INC.
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products/Services offered
  - 12.1.5.3 MnM view
    - 12.1.5.3.1 Key strengths
    - 12.1.5.3.2 Strategic choices
    - 12.1.5.3.3 Weaknesses & competitive threats
- 12.1.6 MERCK KGAA
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products/Services offered
- 12.1.7 BIO-RAD LABORATORIES, INC.
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products/Services offered
- 12.1.8 BIO-TECHNE
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products/Services offered
  - 12.1.8.3 Recent developments
    - 12.1.8.3.1 Deals
    - 12.1.8.3.2 Other developments
- 12.1.9 BECTON, DICKINSON AND COMPANY (BD)
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products/Services offered
- 12.1.10 TAKARA BIO INC.
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products/Services offered
- 12.1.11 ENZO BIOCHEM INC.
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products/Services offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Expansions
- 12.1.12 SINO BIOLOGICAL, INC.
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products/Services offered
- 12.1.13 SAKURA FINETEK JAPAN CO., LTD.
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products/Services offered
  - 12.1.13.3 Recent developments
    - 12.1.13.3.1 Product launches
    - 12.1.13.3.2 Deals
- 12.1.14 CELL SIGNALING TECHNOLOGY, INC.
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products/Services offered
  - 12.1.14.3 Recent developments
    - 12.1.14.3.1 Deals
- 12.1.15 BIO SB
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products/Services offered
  - 12.1.15.3 Recent developments
    - 12.1.15.3.1 Product launches
- 12.1.16 MILTENYI BIOTEC
  - 12.1.16.1 Business overview
  - 12.1.16.2 Products/Services offered
- 12.1.17 ORIGENE TECHNOLOGIES, INC.
  - 12.1.17.1 Business overview
  - 12.1.17.2 Products/Services offered
12.2 OTHER PLAYERS
- 12.2.1 EAGLEBIO
- 12.2.2 BIOCARE MEDICAL, LLC
- 12.2.3 ELABSCIENCE
- 12.2.4 BIOGENEX
- 12.2.5 DIAGNOSTIC BIOSYSTEMS INC.
- 12.2.6 HISTO-LINE LABORATORIES
- 12.2.7 ROCKLAND IMMUNOCHEMICALS, INC.
- 12.2.8 CANDOR BIOSCIENCE GMBH
- 12.2.9 GENEMED BIOTECHNOLOGIES, INC.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

Product Code: BT 4780

List of Tables

TABLE 1 IMMUNOHISTOCHEMISTRY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 IMMUNOHISTOCHEMISTRY MARKET: RISK ANALYSIS
TABLE 4 IMMUNOHISTOCHEMISTRY MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 5 CPT CODES FOR IMMUNOHISTOCHEMISTRY PROCEDURES
TABLE 6 AVERAGE SELLING PRICE TREND OF IMMUNOHISTOCHEMISTRY PRODUCTS, BY KEY PLAYER, 2022-2024 (USD MILLION)
TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024 (USD MILLION)
TABLE 8 AVERAGE SELLING PRICE TREND OF KITS, BY REGION, 2022-2024 (USD MILLION)
TABLE 9 AVERAGE SELLING PRICE TREND OF ANTIBODIES, BY REGION, 2022-2024 (USD MILLION)
TABLE 10 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
TABLE 11 LIST OF KEY PATENTS IN IMMUNOHISTOCHEMISTRY MARKET, 2023-2025
TABLE 12 IMPORT DATA FOR HS CODE 3822.00, BY COUNTRY, 2020-2024 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR HS CODE 3822.00, BY COUNTRY, 2020-2024 (USD THOUSAND)
TABLE 14 IMMUNOHISTOCHEMISTRY MARKET: ROLE IN ECOSYSTEM
TABLE 15 IMMUNOHISTOCHEMISTRY MARKET: PORTER'S FIVE FORCES
TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
TABLE 17 KEY BUYING CRITERIA FOR MAJOR END USERS
TABLE 18 IMMUNOHISTOCHEMISTRY MARKET: TARIFF DATA FOR HS CODES 9027.50, 3822.00, AND 3507
TABLE 19 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
TABLE 20 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
TABLE 21 JAPAN: CLASSIFICATION OF IN VITRO DIAGNOSTIC REAGENTS
TABLE 22 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 23 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 LIST OF KEY CONFERENCES & EVENTS IN IMMUNOHISTOCHEMISTRY MARKET, JANUARY 2025-DECEMBER 2026
TABLE 29 INVESTMENT & FUNDING SCENARIO OF KEY PLAYERS IN IMMUNOHISTOCHEMISTRY MARKET, 2022-2025
TABLE 30 KEY PLAYERS IMPLEMENTING AI/GEN AI IN IMMUNOCHEMISTRY MARKET
TABLE 31 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 32 KEY PRODUCT-RELATED TARIFF: LIVE ANIMALS, PRODUCTS OF ANIMAL ORIGIN, AND MISCELLANEOUS CHEMICAL PRODUCTS
TABLE 33 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
TABLE 34 IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 35 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 36 NORTH AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 37 EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 40 MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 41 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 42 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 43 PRIMARY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 44 NORTH AMERICA: PRIMARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 45 EUROPE: PRIMARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC: PRIMARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 LATIN AMERICA: PRIMARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 48 MIDDLE EAST: PRIMARY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 49 GCC COUNTRIES: PRIMARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 50 SECONDARY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 51 NORTH AMERICA: SECONDARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 52 EUROPE: SECONDARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 53 ASIA PACIFIC: SECONDARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 LATIN AMERICA: SECONDARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 55 MIDDLE EAST: SECONDARY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 56 GCC COUNTRIES: SECONDARY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 57 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 58 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 59 NORTH AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 60 EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 63 MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 64 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 65 MONOCLONAL ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 66 NORTH AMERICA: MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 67 EUROPE: MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 68 ASIA PACIFIC: MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 69 LATIN AMERICA: MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 70 MIDDLE EAST: MONOCLONAL ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 71 GCC COUNTRIES: MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 72 POLYCLONAL ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 73 NORTH AMERICA: POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 74 EUROPE: POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 75 ASIA PACIFIC: POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 76 LATIN AMERICA: POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 77 MIDDLE EAST: POLYCLONAL ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 78 GCC COUNTRIES: POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 79 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 80 CLASS I/II ASSAY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 81 NORTH AMERICA: CLASS I/II ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 EUROPE: CLASS I/II ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 83 ASIA PACIFIC: CLASS I/II ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 84 LATIN AMERICA: CLASS I/II ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 85 MIDDLE EAST: CLASS I/II ASSAY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 86 GCC COUNTRIES: CLASS I/II ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 87 CLASS III ASSAY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 88 NORTH AMERICA: CLASS III ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 89 EUROPE: CLASS III ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 90 ASIA PACIFIC: CLASS III ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 91 LATIN AMERICA: CLASS III ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 92 MIDDLE EAST: CLASS III ASSAY ANTIBODIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 93 GCC COUNTRIES: CLASS III ASSAY ANTIBODIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 94 IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 95 IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 96 NORTH AMERICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 97 EUROPE: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 99 LATIN AMERICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 100 MIDDLE EAST: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 101 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 BLOCKING SERA & REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 103 NORTH AMERICA: BLOCKING SERA & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 104 EUROPE: BLOCKING SERA & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC: BLOCKING SERA & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 106 LATIN AMERICA: BLOCKING SERA & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 107 MIDDLE EAST: BLOCKING SERA & REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 108 GCC COUNTRIES: BLOCKING SERA & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 109 CHROMOGENIC SUBSTRATES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 110 NORTH AMERICA: CHROMOGENIC SUBSTRATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 111 EUROPE: CHROMOGENIC SUBSTRATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 ASIA PACIFIC: CHROMOGENIC SUBSTRATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 113 LATIN AMERICA: CHROMOGENIC SUBSTRATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 114 MIDDLE EAST: CHROMOGENIC SUBSTRATES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 115 GCC COUNTRIES: CHROMOGENIC SUBSTRATES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 116 FIXATION REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 117 NORTH AMERICA: FIXATION REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 118 EUROPE: FIXATION REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 ASIA PACIFIC: FIXATION REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 120 LATIN AMERICA: FIXATION REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 121 MIDDLE EAST: FIXATION REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 122 GCC COUNTRIES: FIXATION REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 123 ORGANIC SOLVENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 124 NORTH AMERICA: ORGANIC SOLVENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 125 EUROPE: ORGANIC SOLVENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 126 ASIA PACIFIC: ORGANIC SOLVENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 127 LATIN AMERICA: ORGANIC SOLVENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 128 MIDDLE EAST: ORGANIC SOLVENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 129 GCC COUNTRIES: ORGANIC SOLVENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 130 PROTEOLYTIC ENZYMES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 131 NORTH AMERICA: PROTEOLYTIC ENZYMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 132 EUROPE: PROTEOLYTIC ENZYMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 133 ASIA PACIFIC: PROTEOLYTIC ENZYMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 134 LATIN AMERICA: PROTEOLYTIC ENZYMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 MIDDLE EAST: PROTEOLYTIC ENZYMES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 136 GCC COUNTRIES: PROTEOLYTIC ENZYMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 137 DILUENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 138 NORTH AMERICA: DILUENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 139 EUROPE: DILUENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 140 ASIA PACIFIC: DILUENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 141 LATIN AMERICA: DILUENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 MIDDLE EAST: DILUENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 143 GCC COUNTRIES: DILUENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 144 OTHER REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 145 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 146 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 147 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 148 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 149 MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 150 GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 151 IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 152 IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 153 NORTH AMERICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 154 EUROPE: IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 155 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 LATIN AMERICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 157 MIDDLE EAST: IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 158 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 159 HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 160 NORTH AMERICA: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 161 EUROPE: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 162 ASIA PACIFIC: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 163 LATIN AMERICA: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 164 MIDDLE EAST: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 165 GCC COUNTRIES: HUMAN IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 166 ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 167 NORTH AMERICA: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 168 EUROPE: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 169 ASIA PACIFIC: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 170 LATIN AMERICA: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 171 MIDDLE EAST: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 172 GCC COUNTRIES: ANIMAL IMMUNOHISTOCHEMISTRY KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 173 IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 174 IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 175 NORTH AMERICA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 176 EUROPE: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 177 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 178 LATIN AMERICA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 179 MIDDLE EAST: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 180 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 181 IHC STAINERS MARKET, BY VOLUME, 2023-2030 (UNITS)
TABLE 182 IHC STAINERS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 183 NORTH AMERICA: IHC STAINERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 184 EUROPE: IHC STAINERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 185 ASIA PACIFIC: IHC STAINERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 186 LATIN AMERICA: IHC STAINERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 187 MIDDLE EAST: IHC STAINERS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 188 GCC COUNTRIES: IHC STAINERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 189 SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 190 SAMPLE PREPARATION INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 191 NORTH AMERICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 192 EUROPE: SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 193 ASIA PACIFIC: SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 194 LATIN AMERICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 195 MIDDLE EAST: SAMPLE PREPARATION INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 196 GCC COUNTRIES: SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 TISSUE PROCESSORS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 198 NORTH AMERICA: TISSUE PROCESSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 199 EUROPE: TISSUE PROCESSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 200 ASIA PACIFIC: TISSUE PROCESSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 201 LATIN AMERICA: TISSUE PROCESSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 202 MIDDLE EAST: TISSUE PROCESSORS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 203 GCC COUNTRIES: TISSUE PROCESSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 MICROTOMES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 205 NORTH AMERICA: MICROTOMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 206 EUROPE: MICROTOMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 207 ASIA PACIFIC: MICROTOMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 208 LATIN AMERICA: MICROTOMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 209 MIDDLE EAST: MICROTOMES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 210 GCC COUNTRIES: MICROTOMES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 211 OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 212 NORTH AMERICA: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 213 EUROPE: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 214 ASIA PACIFIC: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 215 LATIN AMERICA: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 216 MIDDLE EAST: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 217 GCC COUNTRIES: OTHER SAMPLE PREPARATION INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 218 IMAGE ANALYSIS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 219 NORTH AMERICA: IMAGE ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 220 EUROPE: IMAGE ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 221 ASIA PACIFIC: IMAGE ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 222 LATIN AMERICA: IMAGE ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 223 MIDDLE EAST: IMAGE ANALYSIS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 224 GCC COUNTRIES: IMAGE ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 225 IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 226 NORTH AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 227 EUROPE: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 228 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 229 LATIN AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 230 MIDDLE EAST: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 231 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 232 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 233 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 234 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 235 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 236 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 237 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 238 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 239 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 240 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 241 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY REGION, 2023-2030 (USD MILLION)
TABLE 242 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 243 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 244 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 245 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 246 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY REGION, 2023-2030 (USD MILLION)
TABLE 247 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 248 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 249 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 250 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 251 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 252 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 253 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 254 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 255 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 256 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 257 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 258 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 259 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 260 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 261 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 262 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 263 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 264 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 265 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 266 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 267 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 268 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 269 IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 270 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 271 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 272 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 273 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 274 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 275 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 276 OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 277 NORTH AMERICA: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 278 EUROPE: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 279 ASIA PACIFIC: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 280 LATIN AMERICA: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 281 MIDDLE EAST: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 282 GCC COUNTRIES: OTHER IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 283 IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 284 IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 285 NORTH AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 286 EUROPE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 287 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 288 LATIN AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 289 MIDDLE EAST: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 290 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 291 IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY REGION, 2023-2030 (USD MILLION)
TABLE 292 NORTH AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 293 EUROPE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 294 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 295 LATIN AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 296 MIDDLE EAST: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY REGION, 2023-2030 (USD MILLION)
TABLE 297 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET FOR DRUG DEVELOPMENT & TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 298 OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 299 NORTH AMERICA: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 300 EUROPE: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 301 ASIA PACIFIC: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 302 LATIN AMERICA: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 303 MIDDLE EAST: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 304 GCC COUNTRIES: OTHER IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 305 IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 306 NORTH AMERICA: IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 307 EUROPE: IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 308 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 309 LATIN AMERICA: IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 310 MIDDLE EAST: IIMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 311 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 312 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 313 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 314 NORTH AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 315 EUROPE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 316 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 317 LATIN AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 318 MIDDLE EAST: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 319 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 320 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 321 NORTH AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 322 EUROPE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 323 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 324 LATIN AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 325 MIDDLE EAST: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 326 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR ACADEMIC INSTITUTIONS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 327 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 328 NORTH AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 329 EUROPE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 330 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 331 LATIN AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 332 MIDDLE EAST: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 333 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 334 IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 335 IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 336 NORTH AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 337 EUROPE: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 338 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 339 LATIN AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 340 MIDDLE EAST: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 341 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 342 IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 343 NORTH AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 344 EUROPE: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 345 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 346 LATIN AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 347 MIDDLE EAST: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 348 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY SERVICES MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 349 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 350 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 351 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 352 NORTH AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 353 NORTH AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 354 NORTH AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 355 NORTH AMERICA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 356 NORTH AMERICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 357 NORTH AMERICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 358 NORTH AMERICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 359 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 360 NORTH AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 361 NORTH AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 362 NORTH AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 363 NORTH AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 364 NORTH AMERICA: KEY MACROINDICATORS
TABLE 365 US: RECENT DEVELOPMENTS IN IMMUNOHISTOCHEMISTRY MARKET
TABLE 366 US: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 367 US: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 368 US: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 369 US: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 370 US: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 371 US: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 372 US: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 373 US: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 374 US: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 375 US: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 376 US: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 377 US: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 378 US: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 379 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 380 CANADA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 381 CANADA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 382 CANADA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 383 CANADA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 384 CANADA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 385 CANADA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 386 CANADA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 387 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 388 CANADA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 389 CANADA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 390 CANADA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 391 CANADA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 392 EUROPE: RECENT DEVELOPMENTS IN IMMUNOHISTOCHEMISTRY MARKET
TABLE 393 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 394 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 395 EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 396 EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 397 EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 398 EUROPE: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 399 EUROPE: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 400 EUROPE: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 401 EUROPE: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 402 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 403 EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 404 EUROPE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 405 EUROPE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 406 EUROPE: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 407 EUROPE: KEY MACROINDICATORS
TABLE 408 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 409 GERMANY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 410 GERMANY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 411 GERMANY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 412 GERMANY: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 413 GERMANY: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 414 GERMANY: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 415 GERMANY: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 416 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 417 GERMANY: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 418 GERMANY: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 419 GERMANY: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 420 GERMANY: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 421 UK: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 422 UK: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 423 UK: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 424 UK: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 425 UK: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 426 UK: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 427 UK: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 428 UK: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 429 UK: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 430 UK: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 431 UK: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 432 UK: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 433 UK: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 434 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 435 FRANCE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 436 FRANCE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 437 FRANCE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 438 FRANCE: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 439 FRANCE: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 440 FRANCE: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 441 FRANCE: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 442 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 443 FRANCE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 444 FRANCE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 445 FRANCE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 446 FRANCE: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 447 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 448 ITALY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 449 ITALY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 450 ITALY: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 451 ITALY: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 452 ITALY: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 453 ITALY: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 454 ITALY: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 455 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 456 ITALY: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 457 ITALY: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 458 ITALY: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 459 ITALY: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 460 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 461 SPAIN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 462 SPAIN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 463 SPAIN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 464 SPAIN: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 465 SPAIN: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 466 SPAIN: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 467 SPAIN: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 468 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 469 SPAIN: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 470 SPAIN: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 471 SPAIN: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 472 SPAIN: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 473 REST OF EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 474 REST OF EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 475 REST OF EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 476 REST OF EUROPE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 477 REST OF EUROPE: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 478 REST OF EUROPE: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 479 REST OF EUROPE: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 480 REST OF EUROPE: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 481 REST OF EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 482 REST OF EUROPE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 483 REST OF EUROPE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 484 REST OF EUROPE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 485 REST OF EUROPE: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 486 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 487 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 488 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 489 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 490 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 491 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 492 ASIA PACIFIC: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 493 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 494 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 495 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 496 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 497 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 498 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 499 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 500 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 501 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 502 CHINA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 503 CHINA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 504 CHINA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 505 CHINA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 506 CHINA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 507 CHINA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 508 CHINA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 509 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 510 CHINA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 511 CHINA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 512 CHINA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 513 CHINA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 514 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 515 JAPAN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 516 JAPAN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 517 JAPAN: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 518 JAPAN: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 519 JAPAN: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 520 JAPAN: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 521 JAPAN: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 522 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 523 JAPAN: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 524 JAPAN: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 525 JAPAN: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 526 JAPAN: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 527 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 528 INDIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 529 INDIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 530 INDIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 531 INDIA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 532 INDIA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 533 INDIA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 534 INDIA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 535 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 536 INDIA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 537 INDIA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 538 INDIA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 539 INDIA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 540 AUSTRALIA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 541 AUSTRALIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 542 AUSTRALIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 543 AUSTRALIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 544 AUSTRALIA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 545 AUSTRALIA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 546 AUSTRALIA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 547 AUSTRALIA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 548 AUSTRALIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 549 AUSTRALIA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 550 AUSTRALIA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 551 AUSTRALIA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 552 AUSTRALIA: IMMUNOHISTOCHEMISTRY SEERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 553 SOUTH KOREA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 554 SOUTH KOREA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 555 SOUTH KOREA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 556 SOUTH KOREA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 557 SOUTH KOREA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 558 SOUTH KOREA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 559 SOUTH KOREA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 560 SOUTH KOREA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 561 SOUTH KOREA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 562 SOUTH KOREA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 563 SOUTH KOREA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 564 SOUTH KOREA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 565 SOUTH KOREA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 566 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 567 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 568 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 569 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 570 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 571 REST OF ASIA PACIFIC: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 572 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 573 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 574 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 575 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 576 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 577 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 578 REST OF ASIA PACIFIC: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 579 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 580 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 581 LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 582 LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 583 LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 584 LATIN AMERICA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 585 LATIN AMERICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 586 LATIN AMERICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 587 LATIN AMERICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 588 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 589 LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 590 LATIN AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 591 LATIN AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 592 LATIN AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 593 LATIN AMERICA: KEY MACROINDICATORS
TABLE 594 BRAZIL: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 595 BRAZIL: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 596 BRAZIL: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 597 BRAZIL: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 598 BRAZIL: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 599 BRAZIL: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 600 BRAZIL: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 601 BRAZIL: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 602 BRAZIL: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 603 BRAZIL: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 604 BRAZIL: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 605 BRAZIL: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 606 BRAZIL: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 607 MEXICO: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 608 MEXICO: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 609 MEXICO: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 610 MEXICO: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 611 MEXICO: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 612 MEXICO: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 613 MEXICO: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 614 MEXICO: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 615 MEXICO: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 616 MEXICO: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 617 MEXICO: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 618 MEXICO: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 619 MEXICO: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 620 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 621 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 622 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 623 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 624 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY INSTRUMENTS & SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 625 REST OF LATIN AMERICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 626 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 627 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 628 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 629 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 630 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 631 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 632 REST OF LATIN AMERICA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 633 MIDDLE EAST: IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 634 MIDDLE EAST: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 635 MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 636 MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 637 MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 638 MIDDLE EAST: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 639 MIDDLE EAST: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 640 MIDDLE EAST: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 641 MIDDLE EAST: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 642 MIDDLE EAST: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 643 MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 644 MIDDLE EAST: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 645 MIDDLE EAST: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 646 MIDDLE EAST: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 647 MIDDLE EAST: KEY MACROINDICATORS
TABLE 648 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 649 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 650 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 651 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 652 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 653 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 654 GCC COUNTRIES: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 655 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 656 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 657 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 658 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 659 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 660 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 661 GCC COUNTRIES: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 662 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 663 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 664 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 665 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 666 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 667 KINGDOM OF SAUDI ARABIA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 668 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 669 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 670 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 671 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 672 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 673 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 674 KINGDOM OF SAUDI ARABIA: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 675 UAE: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 676 UAE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 677 UAE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 678 UAE: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 679 UAE: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 680 UAE: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 681 UAE: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 682 UAE: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 683 UAE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 684 UAE: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 685 UAE: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 686 UAE: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 687 UAE: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 688 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 689 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 690 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 691 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 692 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 693 REST OF GCC COUNTRIES: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 694 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 695 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 696 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 697 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 698 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 699 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 700 REST OF GCC COUNTRIES: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 701 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 702 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 703 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 704 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 705 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 706 REST OF MIDDLE EAST: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 707 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 708 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 709 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 710 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 711 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 712 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 713 REST OF MIDDLE EAST: IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 714 AFRICA: IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 715 AFRICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 716 AFRICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY CLONALITY, 2023-2030 (USD MILLION)
TABLE 717 AFRICA: IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY REGULATORY CLASS, 2023-2030 (USD MILLION)
TABLE 718 AFRICA: IMMUNOHISTOCHEMISTRY INSTRUMENT & SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 719 AFRICA: SAMPLE PREPARATION INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 720 AFRICA: IMMUNOHISTOCHEMISTRY REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 721 AFRICA: IMMUNOHISTOCHEMISTRY KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 722 AFRICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 723 AFRICA: IMMUNOHISTOCHEMISTRY DIAGNOSTIC APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 724 AFRICA: IMMUNOHISTOCHEMISTRY RESEARCH APPLICATIONS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 725 AFRICA: IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 726 AFRICA: KEY MACROINDICATORS
TABLE 727 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMMUNOHISTOCHEMISTRY MARKET
TABLE 728 IMMUNOHISTOCHEMISTRY MARKET: DEGREE OF COMPETITION
TABLE 729 IMMUNOHISTOCHEMISTRY MARKET: REGION FOOTPRINT
TABLE 730 IMMUNOHISTOCHEMISTRY MARKET: OFFERING FOOTPRINT
TABLE 731 IMMUNOHISTOCHEMISTRY MARKET: APPLICATION FOOTPRINT
TABLE 732 IMMUNOHISTOCHEMISTRY MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS
TABLE 733 IMMUNOHISTOCHEMISTRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY OFFERING AND REGION
TABLE 734 IMMUNOHISTOCHEMISTRY MARKET: PRODUCT APPROVALS, JANUARY 2022-AUGUST 2025
TABLE 735 IMMUNOHISTOCHEMISTRY MARKET: DEALS, JANUARY 2022-AUGUST 2025
TABLE 736 IMMUNOHISTOCHEMISTRY MARKET: EXPANSIONS, JANUARY 2022-AUGUST 2025
TABLE 737 IMMUNOHISTOCHEMISTRY MARKET: OTHER DEVELOPMENTS, JANUARY 2022-AUGUST 2025
TABLE 738 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 739 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 740 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-AUGUST 2025
TABLE 741 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 742 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 743 DANAHER CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-AUGUST 2025
TABLE 744 DANAHER CORPORATION: DEALS, JANUARY 2022-AUGUST 2025
TABLE 745 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 746 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 747 AGILENT TECHNOLOGIES, INC.: PRODUCT APPROVALS, JANUARY 2022-AUGUST 2025
TABLE 748 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022-AUGUST 2025
TABLE 749 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022-AUGUST 2025
TABLE 750 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 751 PHC HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 752 PHC HOLDINGS CORPORATION: DEALS, JANUARY 2022-AUGUST 2025
TABLE 753 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 754 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 755 MERCK KGAA: COMPANY OVERVIEW
TABLE 756 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 757 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 758 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 759 BIO-TECHNE: COMPANY OVERVIEW
TABLE 760 BIO-TECHNE: PRODUCTS/SERVICES OFFERED
TABLE 761 BIO-TECHNE: DEALS, JANUARY 2022-AUGUST 2025
TABLE 762 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2022-AUGUST 2025
TABLE 763 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
TABLE 764 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS/SERVICES OFFERED
TABLE 765 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 766 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 767 ENZO BIOCHEM INC.: COMPANY OVERVIEW
TABLE 768 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED
TABLE 769 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2022-AUGUST 2025
TABLE 770 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
TABLE 771 SINO BIOLOGICAL, INC.: PRODUCTS/SERVICES OFFERED
TABLE 772 SAKURA FINETEK JAPAN CO., LTD.: COMPANY OVERVIEW
TABLE 773 SAKURA FINETEK JAPAN CO., LTD.: PRODUCTS/SERVICES OFFERED
TABLE 774 SAKURA FINETEK JAPAN CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022-AUGUST 2025
TABLE 775 SAKURA FINETEK JAPAN CO., LTD.: DEALS, JANUARY 2022-AUGUST 2025
TABLE 776 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 777 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED
TABLE 778 CELL SIGNALING TECHNOLOGY, INC.: DEALS, JANUARY 2022-AUGUST 2025
TABLE 779 BIO SB: COMPANY OVERVIEW
TABLE 780 BIO SB: PRODUCTS/SERVICES OFFERED
TABLE 781 BIO SB: PRODUCT LAUNCHES, JANUARY 2022-AUGUST 2025
TABLE 782 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 783 MILTENYI BIOTEC: PRODUCTS/SERVICES OFFERED
TABLE 784 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 785 ORIGENE TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 786 EAGLEBIO: COMPANY OVERVIEW
TABLE 787 BIOCARE MEDICAL, LLC: COMPANY OVERVIEW
TABLE 788 ELABSCIENCE: COMPANY OVERVIEW
TABLE 789 BIOGENEX: COMPANY OVERVIEW
TABLE 790 DIAGNOSTIC BIOSYSTEMS INC.: COMPANY OVERVIEW
TABLE 791 HISTO-LINE LABORATORIES: COMPANY OVERVIEW
TABLE 792 ROCKLAND IMMUNOCHEMICALS, INC.: COMPANY OVERVIEW
TABLE 793 CANDOR BIOSCIENCE GMBH: COMPANY OVERVIEW
TABLE 794 GENEMED BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW

List of Figures

FIGURE 1 IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 IMMUNOHISTOCHEMISTRY MARKET: YEARS CONSIDERED
FIGURE 3 IMMUNOHISTOCHEMISTRY MARKET: RESEARCH DESIGN
FIGURE 4 IMMUNOHISTOCHEMISTRY MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
FIGURE 5 IMMUNOHISTOCHEMISTRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 6 IMMUNOHISTOCHEMISTRY MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2024
FIGURE 7 COMPANY REVENUE ANALYSIS: ILLUSTRATIVE EXAMPLE OF F. HOFFMANN-LA ROCHE LTD. (2024)
FIGURE 8 IMMUNOHISTOCHEMISTRY MARKET: KEY INSIGHTS FROM PRIMARIES
FIGURE 9 IMMUNOHISTOCHEMISTRY SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 10 IMMUNOHISTOCHEMISTRY MARKET: CAGR PROJECTIONS
FIGURE 11 IMMUNOHISTOCHEMISTRY MARKET: DATA TRIANGULATION
FIGURE 12 IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 13 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 14 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 15 IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 16 IMMUNOHISTOCHEMISTRY MARKET: REGIONAL ANALYSIS
FIGURE 17 GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, GROWTH RATE, AND FORECAST (USD MILLION)
FIGURE 18 INCREASING ADOPTION OF COMPANION DIAGNOSTICS IN IMMUNOHISTOCHEMISTRY TO PROPEL MARKET GROWTH
FIGURE 19 US AND DIAGNOSTIC APPLICATIONS COMMANDED LARGEST NORTH AMERICAN IMMUNOHISTOCHEMISTRY MARKET SHARE IN 2024
FIGURE 20 HOSPITALS & DIAGNOSTIC LABORATORIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 21 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
FIGURE 22 IMMUNOHISTOCHEMISTRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 SHARE OF PERSONALIZED MEDICINES APPROVED BY FDA (2015-2024)
FIGURE 24 IMMUNOHISTOCHEMISTRY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
FIGURE 25 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)
FIGURE 26 AVERAGE SELLING PRICE OF KITS, BY KEY PLAYER, 2024 (USD)
FIGURE 27 AVERAGE SELLING PRICE OF ANTIBODIES, BY KEY PLAYER, 2024 (USD)
FIGURE 28 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD MILLION)
FIGURE 29 AVERAGE SELLING PRICE OF KITS, BY REGION, 2024 (USD MILLION)
FIGURE 30 AVERAGE SELLING PRICE OF ANTIBODIES, BY REGION, 2024 (USD MILLION)
FIGURE 31 PATENT APPLICATIONS IN IMMUNOHISTOCHEMISTRY MARKET, JANUARY 2014-DECEMBER 2024
FIGURE 32 IMMUNOHISTOCHEMISTRY MARKET: VALUE CHAIN ANALYSIS
FIGURE 33 IMMUNOHISTOCHEMISTRY MARKET: ECOSYSTEM ANALYSIS
FIGURE 34 IMMUNOHISTOCHEMISTRY MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 36 KEY BUYING CRITERIA FOR MAJOR END USERS
FIGURE 37 US: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 38 CANADA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 39 EUROPE: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 40 JAPAN: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 41 INDIA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 42 BRAZIL: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
FIGURE 43 FUNDING AND NUMBER OF DEALS IN IMMUNOHISTOCHEMISTRY MARKET, 2022-2025 (USD MILLION)
FIGURE 44 IMPACT OF AI/GEN AI ON IMMUNOHISTOCHEMISTRY MARKET
FIGURE 45 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
FIGURE 46 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN IMMUNOHISTOCHEMISTRY MARKET, 2020-2024 (USD MILLION)
FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IMMUNOHISTOCHEMISTRY MARKET (2024)
FIGURE 49 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 50 IMMUNOHISTOCHEMISTRY MARKET: COMPANY FOOTPRINT
FIGURE 51 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 52 EV/EBITDA OF KEY VENDORS
FIGURE 53 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 54 IMMUNOHISTOCHEMISTRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 56 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 57 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 58 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
FIGURE 59 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 61 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 62 BIO-TECHNE: COMPANY SNAPSHOT
FIGURE 63 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
FIGURE 64 TAKARA BIO INC.: COMPANY SNAPSHOT
FIGURE 65 ENZO BIOCHEM INC.: COMPANY SNAPSHOT

Immunohistochemistry Market by Product & Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) - Global Forecast to 2030

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION

8 IMMUNOHISTOCHEMISTRY PRODUCTS MARKET, BY END USER

9 IMMUNOHISTOCHEMISTRY SERVICES MARKET, BY END USER

10 IMMUNOHISTOCHEMISTRY MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

List of Tables

List of Figures